Malin Corporation | MLC - Passivo Circulante





Passivo Circulante Alterar Data
Akebia Therapeutics USD 173.88M 10.95M 2026-03
Alaunos Therapeutics USD 595K 218K 2026-03
ALKERMES USD 599.5M 56.06M 2026-03
Avita Medical AUD 62.68M 77K 2025-12
Dianthus Therapeutics USD 38.28M 7.55M 2026-03
Eurofins Scientific SE EUR 2.43B 344.6M 2025-12
Ionis Pharmaceuticals USD 717M 66M 2026-03
IQVIA Holdings USD 8.33B 9M 2026-03
Lonza CHF 3.57B 421M 2025-12
Malin Corporation EUR 1000K 500K 2024-12
Moderna USD 2.4B 408M 2026-03
Organon & Co USD 2.5B 110M 2026-03
Ovoca Bio EUR 186K 2.26M 2025-06
Revvity USD 1.24B 92.6M 2026-03
Tectonic Therapeutic USD 12.96M 3.29M 2026-03
Viatris USD 6.81B 284M 2026-03
Xeris Pharmaceuticals USD 118.59M 9.02M 2026-03